Neurocrine Biosciences Inc
XBER:NB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurocrine Biosciences Inc
XBER:NB3
|
US |
|
E
|
Elders Ltd
F:FTZ
|
AU |
|
B
|
Bitcoin Depot Inc
NASDAQ:BTM
|
US |
|
S
|
Secure Energy Services Inc
OTC:SECYF
|
CA |
|
Compagnie Immobiliere de Belgique
XBRU:IMMO
|
BE |
|
Star Micronics Co Ltd
F:2ZN
|
JP |
|
E
|
Emmi AG
XBER:FV6
|
CH |
|
A
|
Alpha Systems Inc
XMUN:AN5
|
JP |
|
Gerresheimer AG
OTC:GRRMF
|
DE |
|
F
|
Fortec Elektronik AG
SWB:FEV
|
DE |
|
E
|
Exelon Corp
DUS:PEO
|
US |
|
B
|
Bradda Head Lithium Limited
F:8CD1
|
IM |
|
E
|
Elior Group SA
SWB:21E
|
FR |
|
N
|
Northern Superior Resources Inc
OTC:NSUPF
|
CA |
|
Stockland Corporation Ltd
ASX:SGP
|
AU |
|
Assembly Biosciences Inc
F:V7B
|
US |
|
O
|
Ocado Group PLC
XBER:0OC
|
UK |
|
B
|
Burlington Stores Inc
XBER:BUI
|
US |
|
P
|
Pulmatrix Inc
F:2PU1
|
US |
|
Transgene SA
OTC:TRGNF
|
FR |
|
A
|
Argosy Minerals Ltd
OTC:ARYMF
|
AU |
|
G
|
Gildan Activewear Inc
NYSE:GIL
|
CA |
|
PDF Solutions Inc
NASDAQ:PDFS
|
US |
|
Bonheur ASA
F:V7P
|
NO |
Wall St Price Targets
NB3 Price Targets Summary
Neurocrine Biosciences Inc
According to Wall Street analysts, the average 1-year price target for NB3 is 133.61 EUR with a low forecast of 99.11 EUR and a high forecast of 176.02 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NB3's stock price target?
Price Target
133.61
EUR
According to Wall Street analysts, the average 1-year price target for NB3 is 133.61 EUR with a low forecast of 99.11 EUR and a high forecast of 176.02 EUR.
What is the Revenue forecast for Neurocrine Biosciences Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Neurocrine Biosciences Inc?
Projected CAGR
13%
The compound annual growth rate for Gross Profit over the next 8 years is 13%.
What is the Operating Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Operating Income has been 53%. The projected CAGR for the next 8 years is 26%.
What is the Pre-Tax Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
38%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 46%. The projected CAGR for the next 3 years is 38%.
What is the Net Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 30%.
